dc.contributor.author | Coomans de Brachène, A | |
dc.contributor.author | Alvelos, MI | |
dc.contributor.author | Szymczak, F | |
dc.contributor.author | Zimath, PL | |
dc.contributor.author | Castela, A | |
dc.contributor.author | Marmontel de Souza, B | |
dc.contributor.author | Roca Rivada, A | |
dc.contributor.author | Marín-Cañas, S | |
dc.contributor.author | Yi, X | |
dc.contributor.author | Op de Beeck, A | |
dc.contributor.author | Morgan, NG | |
dc.contributor.author | Sonntag, S | |
dc.contributor.author | Jawurek, S | |
dc.contributor.author | Title, AC | |
dc.contributor.author | Yesildag, B | |
dc.contributor.author | Pattou, F | |
dc.contributor.author | Kerr-Conte, J | |
dc.contributor.author | Montanya, E | |
dc.contributor.author | Nacher, M | |
dc.contributor.author | Marselli, L | |
dc.contributor.author | Marchetti, P | |
dc.contributor.author | Richardson, SJ | |
dc.contributor.author | Eizirik, DL | |
dc.date.accessioned | 2024-08-05T14:37:59Z | |
dc.date.issued | 2024-02-26 | |
dc.date.updated | 2024-08-05T13:35:39Z | |
dc.description.abstract | AIMS/HYPOTHESIS: The proinflammatory cytokines IFN-α, IFN-γ, IL-1β and TNF-α may contribute to innate and adaptive immune responses during insulitis in type 1 diabetes and therefore represent attractive therapeutic targets to protect beta cells. However, the specific role of each of these cytokines individually on pancreatic beta cells remains unknown. METHODS: We used deep RNA-seq analysis, followed by extensive confirmation experiments based on reverse transcription-quantitative PCR (RT-qPCR), western blot, histology and use of siRNAs, to characterise the response of human pancreatic beta cells to each cytokine individually and compared the signatures obtained with those present in islets of individuals affected by type 1 diabetes. RESULTS: IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes, and the level of expression of specific IFN-stimulated genes is positively correlated with proteins present in islets of these individuals, regulating beta cell responses to 'danger signals' such as viral infections. Zinc finger NFX1-type containing 1 (ZNFX1), a double-stranded RNA sensor, was identified as highly induced by IFNs and shown to play a key role in the antiviral response in beta cells. CONCLUSIONS/INTERPRETATION: These data suggest that IFN-α and IFN-γ are key cytokines at the islet level in human type 1 diabetes, contributing to the triggering and amplification of autoimmunity. | en_GB |
dc.description.sponsorship | Juvenile Diabetes Research Foundation | en_GB |
dc.description.sponsorship | Dutch Diabetes Research Foundation | en_GB |
dc.description.sponsorship | National Institutes of Health (NIH) | en_GB |
dc.description.sponsorship | Innovative Medicines Initiative 2 Joint Undertaking | en_GB |
dc.description.sponsorship | Fonds National de la Recherche Scientifique (FNRS) | en_GB |
dc.description.sponsorship | Fondation ULB | en_GB |
dc.description.sponsorship | Wallonie-Bruxelles International (WBI) | en_GB |
dc.description.sponsorship | China Scholarship Council | en_GB |
dc.description.sponsorship | Instituto de Salud Carlos III | en_GB |
dc.format.extent | 908-927 | |
dc.identifier.citation | Vol. 67, No. 5, pp. 908-927 | en_GB |
dc.identifier.doi | https://doi.org/10.1007/s00125-024-06106-7 | |
dc.identifier.grantnumber | 3-SRA-2022-1201-S-B [1] | en_GB |
dc.identifier.grantnumber | 3-SRA-2022-1201-S-B [2] | en_GB |
dc.identifier.grantnumber | WELBIO-CR-2019C-04 | en_GB |
dc.identifier.grantnumber | U01 DK127786 | en_GB |
dc.identifier.grantnumber | RO1DK126444 | en_GB |
dc.identifier.grantnumber | RO1DK133881-01 | en_GB |
dc.identifier.grantnumber | 115797 (INNODIA) | en_GB |
dc.identifier.grantnumber | 945268 (INNODIA HARVEST) | en_GB |
dc.identifier.grantnumber | PI19/00246 | en_GB |
dc.identifier.grantnumber | PI22/00334 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/137021 | |
dc.identifier | ORCID: 0000-0002-1160-6062 (Richardson, Sarah J) | |
dc.language.iso | en | en_GB |
dc.publisher | Springer | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/38409439 | en_GB |
dc.rights.embargoreason | Under embargo until 26 February 2025 in compliance with publisher policy | en_GB |
dc.rights | © 2024 Springer Nature | en_GB |
dc.subject | IFN-α | en_GB |
dc.subject | IFN-γ | en_GB |
dc.subject | IL-1β | en_GB |
dc.subject | Pancreatic beta cells | en_GB |
dc.subject | TNF-α | en_GB |
dc.subject | Type 1 diabetes | en_GB |
dc.subject | ZNFX1 | en_GB |
dc.title | Interferons are key cytokines acting on pancreatic islets in type 1 diabetes | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-08-05T14:37:59Z | |
dc.identifier.issn | 0012-186X | |
exeter.place-of-publication | Germany | |
dc.description | This is the author accepted manuscript. The final version is available from Springer via the DOI in this record | en_GB |
dc.description | Data availability:
All data are available in the main text or the electronic supplementary material (ESM). They are available from the corresponding authors upon reasonable request. All newly generated RNA-seq data that support the findings of the present study have been deposited at GEO under accession code GSE235683. | en_GB |
dc.identifier.eissn | 1432-0428 | |
dc.identifier.journal | Diabetologia | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2024-01-03 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2024-02-26 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-08-05T14:21:25Z | |
refterms.versionFCD | AM | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2024-02-26 | |